Ischemic Heart Disease: Clinical Use of MR

Room C205
13:30 – 15:30

Chairs: Albert de Roos, Keynote Speaker, and Pamela K. Woodard

13:30   Keynote.
13:45   210.  MRI Evaluation of Chest Pain Compatible with Myocardial Ischemia, R.Y. Kwong, A.E. Schussheim, J. London, J. Davis, R.S. Balaban and A.E. Arai, National Institutes of Health, Bethesda, MD, USA.
13:57   211.  Dobutamine Tagged MRI Compared to Dobutamine Echocardiography in the Assessment of Functional Recovery After Myocardial Infarction, C.M. Kramer, M.J. Malkowski, S. Mankad, T.M. Theobald, D.L. Pakstis and W.J. Rogers Jr., University of Virginia, Charlottesville, VA, USA and Allegheny General Hospital, Pittsburgh, PA, USA.
14:09   212.  Comparison of Cine- and Tagged-MRI for Qualitative and Quantitative Assessment of Anti-Ischemic Drug Effect in Patients with Coronary Artery Disease, P. Croisille, M.E. Yerlioglu, M. Janier, M. Ovize and D. Revel, H˘pital Cardiovasculaire L.Pradel, Lyon, France.
14:21   213.  2D and 3D Segmented TurboFLASH for the Visualization of Myocardial Injury, O. Simonetti, R.J. Kim, D.S. Fieno, H. Hillenbrand, E. Wu, J.M. Bundy, J.P. Finn and R.M. Judd, Siemens Medical Systems and Northwestern University Medical School, Chicago, IL, USA.
14:33   214.  Left Ventricular Phase Contrast Velocity Mapping in 34 Patients with Ischaemic Heart Disease, B. Schneider, M. Markl, C. Geiges, J. Winterer, J. Hennig and M. Langer, University of Freiburg, Freiburg, Germany.
14:45   215.  High Resolution T2-Weighted Evaluation of Acute Myocardial Ischaemia Using the Intravascular Contrast Agent NC100150 Injection, T. Bjerner, L.O. Johansson, A. Bj°rnerud, G. Wikstr÷m, H. Ahlstr÷m and A. Hemmingsson, Uppsala University Hospital, Uppsala, Sweden and Nycomed Imaging A/S, Oslo, Norway.
14:57   216.  Examining Stunned Myocardium with Gd-DTPA Enhanced MRI, R.E. Thornhill, F.S. Prato, R.S. Pereira, G. Wisenberg and J. Sykes, Joseph's Health Centre and University of Western Ontario, London, Ontario, Canada.
15:09   217.  Simultaneous Detection and Functional Assessment of Reperfused Acute Myocardial Infarction with Spin-Lock Preparation and Gd-DTPA Enhancement, R. Muthupillai, W.T. Dixon, J.M. Wilson, M. Pereyra, R.I. Pettigrew and S.D. Flamm, Texas Heart Institute, Houston, TX, USA and Philips Medical Systems, Shelton, CT, USA

Return to ISMRM program